Clinical Trial Update: Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating busulfan combined with the FLAG conditioning regimen for allogeneic peripheral blood stem cell transplantation in leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Leukemia | Phase 4 | Status: UNKNOWN